Bitcoin News: Saylor “Sell a Kidney” Call is Now a BTC Exit?
Strategy is making big information because it abandons its never-sell Bitcoin coverage, placing 818,334 BTC, or practically 4% of whole provide, in play as an actively managed treasury asset. CEO Phong Le confirmed on Tuesday’s earnings name that the corporate will now think about promoting BTC to purchase {dollars} or retire debt, offered the commerce is accretive to bitcoin per share. A direct reversal of the philosophy Michael Saylor constructed the complete Strategy model round.
“We will promote Bitcoin when it is advantageous to the corporate.” – @Strategy-CEO @PhongLe https://t.co/KFJBOql40V pic.twitter.com/yKHeF2Bvuw
— Tristan – Blocktrainer.de
(@tristanblcktrnr) May 5, 2026
The place was acquired for $61.81 billion at a median value of $75,500 per coin. A $12.5 billion internet loss in Q1 2026, pushed by the BTC worth decline at first of the yr, offered the monetary stress that pressured the pivot. MSTR shares jumped 3% in after-hours buying and selling on the announcement.
Will Strategy dump its complete stack? It nearly actually is not going to. But pondering of promoting when individuals have been requested to promote their kidneys is not a good look.
Discover: Bitcoin price analysis – key support levels and what breaks them
What Happens to Bitcoin If Strategy Starts Selling?
Strategy’s 818,334 BTC is price $61.8 billion on the common acquisition value, however on the present spot worth of $81,500, the place is valued at $66.8 billion. The quantity is means too huge for a single order e-book to soak up cleanly.
Strategy’s purchases of $500 million–$1 billion in BTC have reliably moved spot costs upward by 2%–4% within the periods following disclosure. The reverse dynamic of a coordinated promote program would face thinner liquidity on the ask facet, significantly under the $75,000–$78,000 help band, the place institutional bids focus.
Any significant disposal would nearly actually route by means of OTC desks and never trade order books. That limits slippage however doesn’t eradicate worth impression. A block sale of 5,000–10,000 BTC would signify one of many largest single institutional transactions in current cycle historical past and would carry vital sign weight no matter execution venue.
Le’s acknowledged situation of promoting solely when it is accretive to bitcoin per share creates a governor on this system. But the market liquidity on the $70,000–$74,000 band is skinny. If BTC breaks under the corporate’s common value foundation, the calculus round debt servicing versus hodling shifts materially.
Forget the News, You Can Buy Bitcoin Hyper and Still Keep Your Kidney
Strategy’s present information is scary for retail Bitcoin holders. People are searching for an asymmetrical upside when BTC is caught below $100K, one thing that has Bitcoin safety, constructed to repair Bitcoin flaws, and doesn’t require promoting a kidney to purchase.
Bitcoin Hyper ($HYPER) is a mission drawing consideration. Positioned because the first-ever Bitcoin Layer 2 with Solana Virtual Machine (SVM) integration, it goals to deal with Bitcoin’s three core limitations concurrently: sluggish transactions, high charges, and restricted programmability.
In brief, Hyper is delivering sub-second finality and low-cost good contract execution whereas inheriting Bitcoin’s safety mannequin.
The presale has raised greater than $32.5 million at a present token worth of $0.0136, with 36% APY staking out there for early members. It’s nonetheless low cost, and at that raised degree, significant institutional and retail urge for food is already current, however the worth stays early-stage by any measure. Keep your kidneys and get Hyper.
Research Bitcoin Hyper earlier than the presale concludes.
The submit Bitcoin News: Saylor “Sell a Kidney” Call is Now a BTC Exit? appeared first on Cryptonews.
